Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ryzen

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding proteinD D Bikle, E Gee, B Halloran, et al.
American Heart Journal|February 1, 1990
Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardiaP T Sager, J Widerhorn, R Petersen, et al.
Archives of Internal Medicine|March 1, 1991
Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study GroupF R Singer, P S Ritch, T E Lad, et al.
American Heart Journal|February 1, 1988
Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac diseaseD L Kulick, R Hong, E Ryzen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiencyR K Rude, J S Adams, E Ryzen, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
The Journal of Clinical Endocrinology and Metabolism|October 1, 1986
Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding proteinD D Bikle, E Gee, B Halloran, et al.
American Heart Journal|February 1, 1990
Prospective evaluation of parenteral magnesium sulfate in the treatment of patients with reentrant AV supraventricular tachycardiaP T Sager, J Widerhorn, R Petersen, et al.
Archives of Internal Medicine|March 1, 1991
Treatment of hypercalcemia of malignancy with intravenous etidronate. A controlled, multicenter study. The Hypercalcemia Study GroupF R Singer, P S Ritch, T E Lad, et al.
American Heart Journal|February 1, 1988
Electrophysiologic effects of intravenous magnesium in patients with normal conduction systems and no clinical evidence of significant cardiac diseaseD L Kulick, R Hong, E Ryzen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 1, 1985
Low serum concentrations of 1,25-dihydroxyvitamin D in human magnesium deficiencyR K Rude, J S Adams, E Ryzen, et al.
Pageof 3